Evidence-driven therapy and assessment portfolio powered by medical-grade software, tailored interactive content, and proprietary peripherals


Next-generation evidence-based, protocolised therapies designed for true restoration of motor, cognitive and cardiovascular function following neural injuries, degeneration & ageing

Find out more


Therapies & technologies that enable clinicians to maximise the delivery of motor and cognitive neurorehabilitation across the continuum of care

Find out more


Diversified digital assessments for high fidelity, reliable quantification of motor and cognitive recovery in patients

Find out more

Pioneering teleneurorehabilitation from the comfort of home

The MindMotion™ GO programme is helping neurological patients globally access therapy from the comfort and safety of their homes. The international programme is in leading sites across the US and Europe – including Mount Sinai Abilities Research Center, Johns Hopkins, the Royal Buckinghamshire Hospital, and PhysioFunction.


Creating the universal platform for brain recovery and learning

Combining our pioneering digital therapeutics, with state-of-the-art motion analytics, cloud and AI technologies and innovative peripherals, we’re creating the universal solution for brain health. A scalable platform that’s adaptable to all clinical and patient needs, it will transform neurorehabilitation as we know it.

Our novel digital therapies are the future of brain repair

Our novel digital therapies are fully immersive worlds that offer patients scientifically rigorous and emotionally engaging experiences to enhance their neurorehabilitation.

“By decoding the mysteries of the brain, we are not only transforming the lives of people with neurological conditions, but the world as we know it.”
Tej Tadi, Founder, MindMaze

Deployed in leading centres around the world, our commercially available digital therapeutics are having a profound impact on the lives of patients and caregivers alike.


years of cutting-edge brain technology innovations


DTX Rx by 2026




Sessions delivered


Regulatory approvals


Issued and pending patents owned by MindMaze


Indications including Stroke, Parkinson’s, TBI, MCI


Papers. conference proceedings, trials, studies


of its kind CAT 3 code

Meet Emily

“Life’s improved a lot since I started using MindMotion GO”

Watch film

Meet Simon

“When I go up a level, I can see my effort is paying off”

Watch film

Meet John

“It gives me confidence, enjoyment, to do things I could do before my stroke”

Watch film

MindMaze Labs applies advanced neuroscience to everyday life

From F1 teams to fashion houses and electronics firms, we are partnering with leading global brands to create innovative products that bring our neuroscience expertise to new audiences.